A Mechanism For The Development Of Obesity-associated Conditions
Tuesday, August 5, 2008 - 21:35
in Health & Medicine
Substances known as endocannabinoids have been implicated in the development of many effects of a high-fat diet, including risk factors for type 2 diabetes. New data have now indicated that these effects of endocannabinoids occur via activation of the protein CB1 in the liver and not the brain. Therefore, targeting liver CB1 might provide an effective way to treat obesity-related medical conditions without the side effects of targeting CB1 in the brain, anxiety and depression.
Read the whole article on Science Daily
More from Science Daily
Related
- A mechanism for the development of obesity-associated conditionsSat, 2 Aug 2008, 9:01:07 EDT
- Study suggests new target for treatment of depressionTue, 28 Apr 2009, 18:49:56 EDT
- The vasculature emerges as a potential therapeutic target in treating ADPKD liver cystsThu, 24 Sep 2009, 4:37:58 EDT
- Potential new drug target for depression identifiedTue, 28 Apr 2009, 18:50:02 EDT
- High levels of physical activity can blunt effect of obesity-related gene, study suggestsMon, 8 Sep 2008, 16:22:52 EDT